INTEGER HOLDINGS CORPORATION Interest Expense Nonoperating
INTEGER HOLDINGS CORPORATION (ITGR) reported Interest Expense Nonoperating of $10.13 million for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-04
- INTEGER HOLDINGS CORPORATION interest expense nonoperating for the quarter ending 2026-07-03 was $10.13M, a 3.91% increase year-over-year.
- INTEGER HOLDINGS CORPORATION interest expense nonoperating for the quarter ending 2026-04-03 was $9.73M, a 34.25% decline year-over-year.
- INTEGER HOLDINGS CORPORATION interest expense nonoperating for the quarter ending 2025-12-31 was $9.28M, a 29.88% decline year-over-year.
- INTEGER HOLDINGS CORPORATION interest expense nonoperating for the quarter ending 2025-09-26 was $9.37M, a 35.74% decline year-over-year.
- INTEGER HOLDINGS CORPORATION interest expense nonoperating for fiscal 2025 was $43.21M, a 23.36% decline from fiscal 2024.
- INTEGER HOLDINGS CORPORATION interest expense nonoperating for fiscal 2024 was $56.37M, a 9.94% increase from fiscal 2023.
- INTEGER HOLDINGS CORPORATION interest expense nonoperating for fiscal 2023 was $51.27M, a 37.60% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION interest expense nonoperating for fiscal 2022 was $37.27M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 3 month as first filed | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 6 month as first filed | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|---|---|
| 2026-07-03 | $10.13M 10-Q · filed 2026-08-04 | $19.87M 10-Q · filed 2026-08-04 | $29.15M derived: sum of 3 quarters · filed 2026-08-04 | $38.52M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-04-03 | $9.73M 10-Q · filed 2026-04-30 | $19.01M derived: sum of 2 quarters · filed 2026-04-30 | $28.38M derived: sum of 3 quarters · filed 2026-04-30 | $38.13M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | $9.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $18.65M derived: sum of 2 quarters · filed 2026-02-23 | $28.40M derived: sum of 3 quarters · filed 2026-08-04 | $43.21M 10-K · filed 2026-02-23 | ||
| 2025-09-26 | $9.37M 10-Q · filed 2025-10-23 | $19.12M derived: sum of 2 quarters · filed 2026-08-04 | $33.93M 10-Q · filed 2025-10-23 | $47.16M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-27 | $9.75M 10-Q · filed 2026-08-04 | $24.56M 10-Q · filed 2026-08-04 | $37.79M derived: sum of 3 quarters · filed 2026-08-04 | $52.37M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-28 | $14.80M 10-Q · filed 2026-04-30 | $28.04M derived: sum of 2 quarters · filed 2026-04-30 | $42.62M derived: sum of 3 quarters · filed 2026-04-30 | $57.19M derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $13.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $27.81M derived: sum of 2 quarters · filed 2026-02-23 | $42.38M derived: sum of 3 quarters · filed 2026-02-23 | $56.37M 10-K · filed 2026-02-23 | ||
| 2024-09-27 | $14.58M 10-Q · filed 2025-10-23 | $29.15M derived: sum of 2 quarters · filed 2025-10-23 | $43.14M 10-Q · filed 2025-10-23 | $55.19M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2024-06-28 | $14.57M 10-Q · filed 2025-07-24 | $15.28M 10-Q · filed 2024-07-25 | $28.56M 10-Q · filed 2025-07-24 | $29.95M 10-Q · filed 2024-07-25 | $40.62M derived: sum of 3 quarters · filed 2026-02-23 | $52.11M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-29 | $13.99M 10-Q · filed 2025-04-24 | $26.05M derived: sum of 2 quarters · filed 2026-02-23 | $37.54M derived: sum of 3 quarters · filed 2026-02-23 | $49.00M derived: sum of 4 quarters · filed 2026-02-23 | ||
| 2023-12-31 | $12.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $23.55M derived: sum of 2 quarters · filed 2026-02-23 | $35.01M derived: sum of 3 quarters · filed 2026-02-23 | $51.27M 10-K · filed 2026-02-23 | ||
| 2023-09-29 | $11.49M 10-Q · filed 2024-10-24 | $22.95M derived: sum of 2 quarters · filed 2024-10-24 | $39.22M 10-Q · filed 2024-10-24 | |||
| 2023-06-30 | $11.46M 10-Q · filed 2024-07-25 | $28.71M 10-Q · filed 2024-07-25 | ||||
| 2022-12-31 | $37.27M 10-K · filed 2025-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |